Ordering
Available Variants5 mg
CHA.84858-5mg
Price
€115.20
Available – Dispatch in 14 days
25 mg
CHA.84858-25mg
Price
€568.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.84858-5mg | €115.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.84858-25mg | €568.80 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C16H10ClF4NO2 |
|---|---|
| CAS Number | 187523-35-9 |
| Molecular Weight | 359.70 |
| NACRES | NA.77 |
| PubChem Substance ID | 329825778 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD09475617 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H315,H319,H335 |
| pcodes | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
BMS 204352, also known by its CAS number 187523-35-9, is a synthetic compound that has been investigated for its potential therapeutic applications. This molecule exhibits a unique mechanism of action, interacting with specific biological targets to modulate cellular responses. Research has focused on the compounds ability to influence various signaling pathways, which are crucial for maintaining normal cellular function. Studies have demonstrated that BMS 204352 can effectively regulate these pathways, leading to potential benefits in the treatment of certain diseases. Further investigation is necessary to fully elucidate the compounds effects and to determine its suitability for clinical use. Ongoing research aims to characterize the compounds pharmacological profile and to explore its potential as a therapeutic agent for a range of indications.
